Pune, Maharashtra -- (SBWire) -- 05/28/2019 --According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments. Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.
Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.\
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=719
Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails' Success
Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. Integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in current clinical trial environment.
CROs are essential and play a key role in ensuring the clinical trials' success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance. CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to quality and integrity of clinical trials apropos of vocal biomarkers.
Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis' Upward Trend
Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson's disease.
Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders. Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately US$ 130 Mn by 2027-end.
Browse Full Report @ https://www.factmr.com/report/719/vocal-biomarker-market
North America Vocal Biomarker Market: Driven by Government Agencies' Tie-ups with Voice-Related Companies
Robust healthcare infrastructure, and presence of well-funded research organizations equipped with cutting-edge technologies in North America have made the region a lucrative breeding place for vocal biomarkers. Tie-ups of the U.S. government agencies with voice-based companies and analysis researchers is a primary demand determinant for vocal biomarkers in the region across areas such as geriatrics and war-induced trauma. For example, the U.S. Army entered into a collaboration with researchers from MIT for developing voice-based detection system to diagnose brain injuries.
Fact.MR's report foresees the global market for vocal biomarker to reflect a staggering expansion in the period of forecast, 2018 to 2027. Over US$ 390 Mn worth of vocal biomarkers are envisaged to be sold across the globe by 2027-end.
To deliver a seamless understanding of the Vocal Biomarker market, the report is divided into 18 sophisticated chapters whose snapshots are provided below.
Chapter 1 – Executive Summary
The report commences with the chapter of the executive summary which delivers brief yet affluent information of the Vocal Biomarker market. The chapter includes discussion on the market overview, market analysis and market recommendations regarding the Vocal Biomarker market derived based on Fact.MR's proprietary wheel of fortune.
Chapter 2 – Market Introduction
In the market introduction chapter, the Vocal Biomarker market is introduced along with the
market segmentation in the form of market taxonomy. The chapter also introduces the Vocal Biomarker in the market definition section.
Chapter 3 - Vocal Biomarker Market Background
In this chapter, macroeconomic factors, market dynamics, a complete value chain and pricing
analysis with regard to Vocal Biomarker market is elaborately discussed. Discussion on the
market drivers, restraints, trends and opportunities and their impact on the market forecast is also
covered in this chapter.
You can Buy This Report from Here @ https://www.factmr.com/checkout/719/S
Chapter 4 - Global Vocal Biomarker Market Analysis 2013–2017 and Forecast 2018–2026
This chapter provides the Vocal Biomarker market size in terms of market volume and value
during the forecast period. Market analysis based on absolute $ opportunity and y-o-y growth of the Vocal Biomarker market is also covered in this chapter.
Chapter 5 - Global Vocal Biomarker Market Analysis 2013–2017 and Forecast 2018–2026,
By System Type Based on system types in the Vocal Biomarker market, the chapter elaborates market size of individual systems and analysis by system types and summary of this section is covered in the chapter.
Chapter 6 - Global Vocal Biomarker Market Analysis 2013–2017 and Forecast 2018–2026, By Application
Based on applications, Market size of individual applications, their market attractiveness analysis and summary are also covered.
Chapter 7 - Global Vocal Biomarker Market Analysis 2013–2017 and Forecast 2018–2026, By End User
This chapter elaborates the segmentation of the Vocal Biomarker market based on end users
including independent end users, Market attractive analysis by end users is also discussed to fathom relative lucrativeness of different end users of the Vocal Biomarker market.
Chapter 8 - Global Vocal Biomarker Market Analysis 2013–2017 and Forecast 2018–2026, By Region
With the geographical perspective, the Vocal Biomarker market is analyzed on a total of seven regions including North America, Latin America, Europe, South East Asia & Pacific, Middle East & Africa, China and Japan. Historical data and prevailing trends in the Vocal Biomarker market and their influence on the global market performance is discussed in this chapter.
And Continue....
Vocal Biomarker Market : Advancements and Efficient Clinical Outcomes Would Drive the Industry Growth with Top Key Player's Analysis
Fact.MR has announced the addition of the “ Vocal Biomarker Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.